Further studies using either pharmacological or genetic inhibition of CCL2 and NO demonstrated the role of the Slc4a4 in regulating the CCL2-CCR2 pathway and NO metabolism in the context of BBB recovery after stroke. Here, CCR2 is linked to stroke disorder.